4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001140361-23-040562
President and CEO sold 30,766 shares at an average $1.65 ($50,835)
From the SEC's structured data for this filing
Trades in this filing
Touchon Pascal · President and CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-08-16 | Sale : show line 1 in the form | −21,432 | $1.65 | $35,406 | 685,239 | D |
| 2023-08-16 | Sale : show line 2 in the form | −9,334 | $1.65 | $15,429 | 675,905 | D |
| Open-market sales · 30,766 sh · avg $1.65 · $50,835 | ||||||
Loading xslF345X05/form4.xml…